Several of the serum factors that trended towards change in ALS serum, including fractalkine, BDNF, EGF, PDGF, Dkk-1, MIF, and uPAR, have pro-angiogenic effects [61–67]. Here, BDNF is linked to amyotrophic lateral sclerosis.